In the last years, microRNAs (miRNA) have emerged as new molecular players involved in carcinogenesis. Deregulation of miRNAs expression has been shown in different human cancer but the molecular mechanism underlying the alteration of miRNA expression is unknown. To identify tumor-supressor miRNAs silenced through aberrant epigenetic events in colorectal cancer (CRC), we used a sequential approach. We first identified 5 miRNAs down-regulated in colorectal cancer patient samples and located around/on a CpG island. Treatment with a DNA methyltransferase inhibitor and a HDAC inhibitor restored expression of 3 of the 5 microRNAs 
INTRODUCTION
MicroRNAs (miRNAs) are 19-to 25-nt non coding RNAs that are cleaved from 70-to 100-nt hairpin-shaped precursors 1 . They can regulate gene expression inducing direct mRNA degradation or translational inhibition 2 . miRNAs are expressed in a tissue-specific manner and represent crucial factors in the regulation of different pathways involved in development, cell differentiation, proliferation and apoptosis [3] [4] [5] [6] . Moreover, abnormal regulation of miRNA expression may contribute to the development of human cancer [7] [8] [9] [10] . Interestingly, downregulation of miRNAs has been demonstrated in tumors in comparison with normal tissue 11 , suggesting that some miRNAs may behave as putative tumor suppressor genes 12, 13 . However, although the biological importance of miRNA is becoming increasingly apparent, the molecular mechanism underlying regulation of miRNA expression in cancer is not completely understood.
Specific transcriptional regulation, epigenetic mechanisms including methylation and histone deacetylation, gene mutations affecting proteins involved in the processing and maturation of microRNAs, or regulation of miRNA stability include some of the mechanism involved in the regulation of microRNA expression [14] [15] [16] .
While methylation of CpG dinucleotides in the promoter region of genes is an important mechanism of gene regulation, aberrant hypermethylation of tumor suppressor genes plays a significant role in tumor development 17 . In fact down-regulation of tumor suppressor genes in human cancer has been tightly linked to the presence of CpG island promoter hypermethylation 18, 19 and establishes epigenetic regulation as a key mechanism in tumorigenesis. Interestingly, recent studies indicate that microRNA expression may be regulated by different epigenetic mechanism including abnormal methylation of the promoter regions or histone modifications 20, 21 .
We and others have recently demonstrated that expression of microRNAs is down-regulated in CRC 22 , 9 and two different studies 23, 24 , comparing the miRNA expression profile of the parental HTC116 cell line and the DNA methyltransferase 1 and 3b (DNMT1 and DNMT3b) double knockout cell line suggest that DNA hypermethylation contributes to the transcriptional downregulation of microRNAs in CRC.
4
To explore the role of epigenetic mechanisms in the down-regulation of miRNAs in CRC we examined the presence of DNA methylation and histone modifications-associated silencing of miRNAs and observed that abnormal hypermethylation of the promoters of hsa-miR-9, hsa-miR-129 and hsa-miR-137 is associated with reduced expression in CRC tissues but rare in normal tissue. Our results suggest that DNA hypermethylation and histone modifications contribute to the transcriptional down-regulation of miRNAs and may participate in human colorectal tumorigenesis. and/or 4-phenylbutyric acid (PBA;1 and 3 mM; Sigma). For 5-Aza-2'-deoxycytidine treatment, cells were treated for 4 days and for histone acetylase inhibition, PBA was continuously administered by replacing the medium containing PBA every 24 hr for 5 days. 5-Aza-2'-deoxycytidine with PBA treatment, 5-Aza-2'-deoxycytidine was removed after 48 hrs, while PBA was continuously administered every 24 hr for 5 days.
MATERIAL AND METHODS

Human
miRNA and mRNA expression analysis miRNA expression analysis was performed as previously described 25 . In brief, cDNA was synthesized from total RNA using gene-specific primers according to the TaqMan MicroRNA Assay protocol (Applied Biosystems, Inc., Foster City, CA, USA). Real-time PCR was performed using an Applied Biosystems 7300 Sequence Detection system. The 10 µl PCR included 0.67 µl RT product, 1x TaqMan Universal PCR master mix and 1 µl of primers and probe mix of the TaqMan MicroRNA Assay protocol (Applied Biosystems, Inc.). Expression was normalized using TaqMan microRNA endogenous control assay RNAU6B.
DNA methylation analyses
We searched the human genome database (http://genome.ucsc.edu/) (University of California Santa Cruz, Genome Bioinformatics) for the existence of miRNAs embedded in a CpG island.
Genomic DNA samples were modified by sodium bisulfite using the CpGenome DNA modification kit (Chemicon, Temecula, CA, USA) following the manufacturer's instructions.
The DNA methylation status was analyzed by methylation specific PCR (MSP) after sodium bisulfite modification of DNA. Human male genomic DNA universally methylated for all genes (Intergen Company, Purchase, NY) was used as a positive control for methylated alleles. Water blanks were included with each assay. Primer sequences of MSP of each miRNA are described in Supplementary Table S1 . Following amplification, PCR products were subjected to gel electrophoresis through a 2.5% agarose gel and were visualized by ethidium bromide staining and UV transillumination. The second analysis was realized by bisulfite genomic sequencing (BSP) of both strands of the corresponding CpG islands. Following sodium bisulfite treatment, the 5' region of miRNAs was PCR amplified. PCR products were subcloned using the One Shot® TOP10 kit (Invitrogen) into pCR® 4-TOPO® plasmid and candidate plasmid clones were sequenced. Primer sequences are described in Supplementary Table S1 .
Q-CHIP assay
Colon carcinoma cell lines CACO2 and SW620 before and after treatment with the histone deacetylase inhibitor 4-phenylbutyric acid (PBA) were subjected to chromatin immunoprecipitation. The ChIP assays were performed as previously described 23 
Efficiencies (E) of each amplifications were calculated from the slopes of crossover points (Cp)
vs DNA concentration plot, according to the formula E = 10
. ∆Cp corresponded to the difference between control/calibrator Cp and sample Cp, either for the target or for the reference sequences. The level of AcH3 was determined relative to input chromatin of each sample.
Statistical Analysis
Correlations between methylation state and clinico-pathological features were assessed using χ 2 or Fisher´s Exact probability tests as appropriate. All p-values presented are two-sided. A pvalue < 0.05 was regarded as statistically significant. All statistical tests were performed using the SPSS software package (version 15, SPSS, Chicago, IL).
RESULTS
Identification of epigenetically regulated miRNAs in human colorectal cancer
We have previously identified 23 miRNAs down-regulated in primary CRC in comparison with matched normal colorectal epithelial tissues 22 . In order to determine whether these microRNAs could be epigenetically regulated we first examined their location in the genome. 
Analysis of miRNAs promoter hypermethylation in CRC
We next examined the methylation of the promoter regions of hsa-miR-9, hsa-miR-129 and hsamiR-137 by MSP to determine whether aberrant hypermethylation is responsible for silencing of miRNAs expression. Hsa-miR-9 is represented by three genomic loci hsa-miR-9-1 (1q22), hsamiR-9-2 (5q14.3), hsa-miR-9-3 (15q26.1). While hsa-miR-9-1 is located at 183bp of a CpG island and hsa-miR-9-3 is embedded in a CpG island, hsa-miR-9-2 is located more than 1000pb Figure S1) .
Methylation of hsa-miR-9-1 and hsa-miR-9-3 loci and expression of hsa-miR-9 showed a
heterogenous behavior ( Figure 2B ). Low-expression of the mature miRNA (hsa-miR-9) was correlated mainly with methylation of hsa-miR-9-1, but not with methylation of the hsa-miR-9-3 as indicated by the fact that the hsa-miR-9-3 locus was found methylated on HCT116 and SW620 cell lines that showed high hsa-miR-9 expression ( Figure 2B and Figure 2C ).
MSP results obtained for hsa-miR-9-1 and hsa-miR-9-3 were confirmed by bisulphite sequencing ( Figure 3A and 3B).
Regulation of microRNA expression by histone 3 acetylation
The fact that expression of microRNAs was upregulated by the combined treatment with 5-Aza-2'-deoxycytidine and PBA suggested that histone acetylation could also be involved in the regulation of microRNA expression. CRC cell lines were subjected to chromatin immunoprecipitation with an antibody against acetylated H3 (a mark of transcriptional active
chromatin) followed by Q-PCR for hsa-miR-9-1, hsa-miR-9-3, hsa-miR-129 and hsa-miR-137
before hsa-miR-9-1 methylation and clinico-pathological features of primary CRC we observed that methylation was more frequent in advanced stages of CRC and was associated with regional nodal invasion (p=0.008), vascular invasion (p=0.004) and metastasis (p=0.016) ( Table 1) .
These results suggest that hsa-miR-9-1 silencing could have a role in the malignant progression of colorectal cancer.
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DISCUSSION
In the current study we have shown the first demonstration that suppression of hsa-miR-9, hsamiR-129 and hsa-miR-137 genes in colorectal cancer is mediated at least in part by epigenetic mechanisms including DNA hypermethylation and histone acetylation. Moreover, the frequent hypermethylation of these miRNA genes in CRC and the correlation between methylation and clinico-pathological supports the concept that epigenetic instability is an important event in human tumorigenesis specifically in colorectal carcinoma.
Epigenetic regulation of miRNAs mediated by inadequate methylation has been previously The differences between methylation of hsa-miR-9-1, hsa-miR-129 and hsa-miR-137 in primary CRC tumors and normal mucosa suggest that similar to classic tumor-supressor genes, DNA methylation could be an important molecular mechanism for the down-regulation of miRNA expression. Moreover, the association between hsa-miR-9-1 methylation and more advanced stages and nodal involvement supports a role for hsa-miR-9-1 methylation as a potential tumor marker of poor outcome in colorectal cancer. However, further investigation would be required to study the involvement of hsa-miR-9-1 in distant metastasis and patient survival.
Other miRNAs has been shown to be hypermethylated in CRC. Methylation of the hsa-miR34b/c CpG island was frequently observed in CRC cell lines and in primary CRC tumors, but not in normal colonic mucosa suggesting a tumor-specific methylation 29 . Moroever, Grady et al 30 showed that the EVL/hsa-hsa-miR-342 locus was methylated in 86% of colorectal adenocarcinomas and in 67% of adenomas, indicating that it is an early event in colorectal carcinogenesis. In addition, similar to our results with hsa-miR-137 they observed a high frequency of methylation (56%) in histologically normal colorectal mucosa from individuals with concurrent cancer, suggesting the existence of a 'field defect' involving miRNAs.
The precise function of hsa-miR-9, hsa-miR-129, and hsa-miR-137 have not been characterized although abnormal expression has been described in tumor samples. Hsa-miR-9 has been described as a putative tumor suppressor gene in recurrent ovarian cancer 31 
